Put Options

24 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$189.07 - $236.8 $3.14 Million - $3.93 Million
-16,600 Reduced 48.82%
17,400 $3.37 Million
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $3.54 Million - $4.4 Million
18,600 Added 120.78%
34,000 $7.88 Million
Q1 2024

May 15, 2024

BUY
$212.02 - $267.71 $1.67 Million - $2.11 Million
7,900 Added 105.33%
15,400 $3.32 Million
Q1 2023

May 15, 2023

SELL
$256.56 - $292.34 $16.3 Million - $18.6 Million
-63,500 Reduced 89.44%
7,500 $2.09 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $22.4 Million - $30.9 Million
-115,000 Reduced 61.83%
71,000 $19 Million
Q1 2022

May 16, 2022

BUY
$193.77 - $244.14 $2.29 Million - $2.88 Million
11,800 Added 6.77%
186,000 $39.2 Million
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $15 Million - $19.2 Million
66,800 Added 62.2%
174,200 $41.8 Million
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $5.24 Million - $6.83 Million
-18,500 Reduced 14.69%
107,400 $30.4 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $9.71 Million - $15.6 Million
37,500 Added 42.42%
125,900 $43.6 Million
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $10.2 Million - $11.9 Million
-41,800 Reduced 32.1%
88,400 $24.7 Million
Q4 2020

Feb 16, 2021

BUY
$236.26 - $355.63 $11.5 Million - $17.4 Million
48,800 Added 59.95%
130,200 $31.9 Million
Q3 2020

Nov 16, 2020

SELL
$264.77 - $305.71 $3.2 Million - $3.7 Million
-12,100 Reduced 12.94%
81,400 $23.1 Million
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $8.85 Million - $11.7 Million
34,200 Added 57.67%
93,500 $25 Million
Q1 2020

May 15, 2020

SELL
$268.85 - $341.04 $21.1 Million - $26.7 Million
-78,400 Reduced 56.94%
59,300 $18.8 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $2.2 Million - $3.04 Million
-10,000 Reduced 6.77%
137,700 $40.9 Million
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $1.67 Million - $1.88 Million
7,700 Added 5.5%
147,700 $34.4 Million
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $15.4 Million - $16.9 Million
70,000 Added 100.0%
140,000 $32.7 Million
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $22.6 Million - $35.4 Million
-104,300 Reduced 59.84%
70,000 $16.5 Million
Q4 2018

Feb 14, 2019

BUY
$278.5 - $352.75 $8.36 Million - $10.6 Million
30,000 Added 20.79%
174,300 $52.5 Million
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $7.19 Million - $9.4 Million
24,500 Added 20.45%
144,300 $51 Million
Q2 2018

Aug 14, 2018

BUY
$257.52 - $306.91 $14 Million - $16.7 Million
54,500 Added 83.46%
119,800 $34.8 Million
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $3.98 Million - $5.63 Million
-15,300 Reduced 18.98%
65,300 $17.9 Million
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $3.63 Million - $4.07 Million
-11,800 Reduced 12.77%
80,600 $25.7 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $26 Million - $30.5 Million
92,400
92,400 $28.9 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.8B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.